Differential X Chromosome Inactivation Patterns during the Propagation of Human Induced Pluripotent Stem Cells.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The Keio Journal of Medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2302/kjm.2016-0015-OAPMID 28111378
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Female human pluripotent stem cells rapidly lose X chromosome inactivation marks and progress to a skewed methylation pattern during culture.

  2016cited by this paper
• Stable X Chromosome Reactivation in Female Human Induced Pluripotent Stem Cells

  2015cited by this paper
• Erosion of X Chromosome Inactivation in Human Pluripotent Cells Initiates with XACT Coating and Depends on a Specific Heterochromatin Landscape.

  2015cited by this paper
• Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage

  2015cited by this paper
• Derivation of naïve human embryonic stem cells

  2014cited by this paper
• X chromosome reactivation dynamics reveal stages of reprogramming to pluripotency.

  2014cited by this paper
• Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons.

  2014cited by this paper
• Derivation of novel human ground state naive pluripotent stem cells

  2013cited by this paper
• Comparison of Genomic and Epigenomic Expression in Monozygotic Twins Discordant for Rett Syndrome

  2013cited by this paper
• Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives.

  2012cited by this paper
• Derivation of new human embryonic stem cell lines reveals rapid epigenetic progression in vitro that can be prevented by chemical modification of chromatin.

  2012cited by this paper
• Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability

  2012cited by this paper
• Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells.

  2012cited by this paper
• Erosion of dosage compensation impacts human iPSC disease modeling.

  2012cited by this paper
• Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue

  2012cited by this paper
• Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes.

  2012cited by this paper
• Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation

  2011cited by this paper
• Modeling familial Alzheimer's disease with induced pluripotent stem cells.

  2011cited by this paper
• Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

  2011cited by this paper
• DNA Methylation Dynamics in Human Induced Pluripotent Stem Cells over Time

  2011cited by this paper
• Copy number variation and selection during reprogramming to pluripotency

  2011cited by this paper
• Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines.

  2011cited by this paper
• Isogenic Pairs of Wild Type and Mutant Induced Pluripotent Stem Cell (iPSC) Lines from Rett Syndrome Patients as In Vitro Disease Model

  2011cited by this paper
• Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells.

  2011cited by this paper
• Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase.

  2011cited by this paper
• Karyotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells

  2011cited by this paper
• Female human iPSCs retain an inactive X chromosome.

  2010cited by this paper
• Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs

  2010cited by this paper
• Identification and classification of chromosomal aberrations in human induced pluripotent stem cells.

  2010cited by this paper
• Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations.

  2010cited by this paper
• Variations of X Chromosome Inactivation Occur in Early Passages of Female Human Embryonic Stem Cells

  2010cited by this paper
• Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells.

  2009cited by this paper
• X‐inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected

  2008cited by this paper
• X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells

  2008cited by this paper
• Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons

  2008cited by this paper
• Disease-specific induced pluripotent stem cells.

  2008cited by this paper
• X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations

  2008cited by this paper
• Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

  2007cited by this paper
• Derivation of pluripotent epiblast stem cells from mammalian embryos

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• New cell lines from mouse epiblast share defining features with human embryonic stem cells

  2007cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Balanced X chromosome inactivation patterns in the Rett syndrome brain.

  2002cited by this paper
• Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes

  2000cited by this paper
• A new assay for the analysis of X-chromosome inactivation based on methylation-specific PCR

  1999cited by this paper
• Embryonic stem cell lines derived from human blastocysts.

  1998cited by this paper
• Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation.

  1992cited by this paper
• Patterns of X chromosome inactivation in the Rett syndrome.

  1990cited by this paper
• Rett's Syndrome: Prevalence and Impact on Progressive Severe Mental Retardation in Girls

  1985cited by this paper
• A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases

  1983cited by this paper
• Sex chromatin and gene action in the mammalian X-chromosome.

  1962cited by this paper
• Gene Action in the X-chromosome of the Mouse (Mus musculus L.)

  1961cited by this paper

• Exploring maternal-fetal interface with in vitro placental and trophoblastic models

  2023cites this paper
• Endogenous versus exogenous cell replacement for Parkinson’s disease: where are we at and where are we going?

  2022cites this paper
• Loss of X Chromosome Inactivation in Androgenetic Complete Hydatidiform Moles With 46, XX Karyotype

  2020cites this paper
• Juntendo Medical Journal

  2020cites this paper
• Addressing Variability and Heterogeneity of Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

  2019cites this paper
• Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

  2018cites this paper
• Neurodevelopmental Disorders and Environmental Toxicants: Epigenetics as an Underlying Mechanism

  2017cites this paper